These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28427470)

  • 1. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
    Freitas CSG; Baldi BG; Jardim C; Araujo MS; Sobral JB; Heiden GI; Kairalla RA; Souza R; Carvalho CRR
    Orphanet J Rare Dis; 2017 Apr; 12(1):74. PubMed ID: 28427470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features of pulmonary hypertension in lymphangioleiomyomatosis].
    Liang PQ; Xu BN; Pan YX; Huang HY; Zhao Z; Hong C; Wu XF; Liu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Aug; 47(8):746-753. PubMed ID: 39069851
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients.
    Cottin V; Harari S; Humbert M; Mal H; Dorfmüller P; Jaïs X; Reynaud-Gaubert M; Prevot G; Lazor R; Taillé C; Lacronique J; Zeghmar S; Simonneau G; Cordier JF;
    Eur Respir J; 2012 Sep; 40(3):630-40. PubMed ID: 22362861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.
    Wu X; Xu W; Wang J; Tian X; Tian Z; Xu K
    Front Med; 2019 Apr; 13(2):259-266. PubMed ID: 29675687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.
    Baldi BG; Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
    Am J Respir Crit Care Med; 2012 Aug; 186(4):341-8. PubMed ID: 22700863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
    Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
    Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does reduced lung diffusing capacity for carbon monoxide predict the presence of pulmonary hypertension?
    Delcour KS; Singla A; Jarbou M; Alpert M; Dabbagh O
    Am J Med Sci; 2010 Jul; 340(1):54-9. PubMed ID: 20463574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis.
    Hua W; Yang W; Gu J; Wu J; Wang W; Liu Y; Zhu H; Zhou M; Qu J; Fang Y
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):439-448. PubMed ID: 32929608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis.
    Diesler R; Cottin V; Gallien Y; Turquier S; Traclet J; Ahmad K; Glerant JC
    Respir Med Res; 2024 Jun; 85():101071. PubMed ID: 38141576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of pulmonary hypertension in sarcoidosis.
    Bourbonnais JM; Samavati L
    Eur Respir J; 2008 Aug; 32(2):296-302. PubMed ID: 18385166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema.
    Minai OA; Fessler H; Stoller JK; Criner GJ; Scharf SM; Meli Y; Nutter B; DeCamp MM;
    Respir Med; 2014 Mar; 108(3):482-90. PubMed ID: 24290900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
    Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
    Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.
    Taveira-DaSilva AM; Hathaway OM; Sachdev V; Shizukuda Y; Birdsall CW; Moss J
    Chest; 2007 Nov; 132(5):1573-8. PubMed ID: 17890459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort.
    Iudici M; Codullo V; Giuggioli D; Riccieri V; Cuomo G; Breda S; Manfredi A; Iannace N; D'Alto M; Ghio S; Rossi R; Vizza CD; Caporali R; Valesini G; Ferri C; Valentini G
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):31-6. PubMed ID: 23910607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
    Steen V; Medsger TA
    Arthritis Rheum; 2003 Feb; 48(2):516-22. PubMed ID: 12571862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography.
    Sonaglioni A; Baravelli M; Cassandro R; Torre O; Elia D; Anzà C; Harari S
    J Am Soc Echocardiogr; 2018 Aug; 31(8):888-901. PubMed ID: 29605474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.